Takeshi Takahashi
Director/Board Member at Pathalys Pharma, Inc.
Takeshi Takahashi active positions
| Companies | Position | Start | End |
|---|---|---|---|
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Director/Board Member | - | - |
Career history of Takeshi Takahashi
Former positions of Takeshi Takahashi
| Companies | Position | Start | End |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director/Board Member | 2020-04-30 | 2023-09-11 |
| Independent Dir/Board Member | 2020-04-30 | 2023-09-11 | |
| TSUGAMI CORPORATION | Chief Operating Officer | 2020-03-31 | - |
| Chief Tech/Sci/R&D Officer | 2020-03-31 | - | |
| Corporate Officer/Principal | - | 2020-03-31 |
Training of Takeshi Takahashi
| Waseda University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 4 |
| Japan | 3 |
Operational
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| TSUGAMI CORPORATION | Producer Manufacturing |
| Private companies | 1 |
|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Health Technology |
- Stock Market
- Insiders
- Takeshi Takahashi
- Experience
